1. Home
  2. OCS vs GETY Comparison

OCS vs GETY Comparison

Compare OCS & GETY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • GETY
  • Stock Information
  • Founded
  • OCS 2003
  • GETY 1995
  • Country
  • OCS Switzerland
  • GETY United States
  • Employees
  • OCS N/A
  • GETY N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • GETY Industrial Machinery/Components
  • Sector
  • OCS Health Care
  • GETY Industrials
  • Exchange
  • OCS Nasdaq
  • GETY Nasdaq
  • Market Cap
  • OCS 689.8M
  • GETY 644.9M
  • IPO Year
  • OCS N/A
  • GETY N/A
  • Fundamental
  • Price
  • OCS $18.58
  • GETY $1.89
  • Analyst Decision
  • OCS Strong Buy
  • GETY Hold
  • Analyst Count
  • OCS 4
  • GETY 5
  • Target Price
  • OCS $31.50
  • GETY $4.60
  • AVG Volume (30 Days)
  • OCS 30.4K
  • GETY 573.1K
  • Earning Date
  • OCS 05-08-2025
  • GETY 05-12-2025
  • Dividend Yield
  • OCS N/A
  • GETY N/A
  • EPS Growth
  • OCS N/A
  • GETY 99.37
  • EPS
  • OCS N/A
  • GETY 0.10
  • Revenue
  • OCS $847,333.00
  • GETY $939,287,000.00
  • Revenue This Year
  • OCS $49.27
  • GETY $2.37
  • Revenue Next Year
  • OCS $1,920.31
  • GETY $2.59
  • P/E Ratio
  • OCS N/A
  • GETY $19.46
  • Revenue Growth
  • OCS N/A
  • GETY 2.48
  • 52 Week Low
  • OCS $10.79
  • GETY $1.25
  • 52 Week High
  • OCS $23.08
  • GETY $4.49
  • Technical
  • Relative Strength Index (RSI)
  • OCS 54.68
  • GETY 50.81
  • Support Level
  • OCS $18.01
  • GETY $1.81
  • Resistance Level
  • OCS $19.50
  • GETY $2.01
  • Average True Range (ATR)
  • OCS 0.77
  • GETY 0.09
  • MACD
  • OCS 0.17
  • GETY 0.01
  • Stochastic Oscillator
  • OCS 66.30
  • GETY 36.96

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About GETY Getty Images Holdings Inc.

Getty Images Holdings Inc. is a visual content creator and marketplace that offers a full range of content solutions. Through its Getty Images, Stock, and Unsplash brands, websites, and APIs, it serves customers around the world by allowing them to discover, purchase, and share visual content from photographers, illustrators, image partners, and videographers. The company generates a majority of its revenue through subscriptions, offering various subscription products on the Getty Images, iStock, and Unsplash websites. It operates and manages one operating segment, which is the business of developing and commercializing visual content. Geographically, the company generates maximum revenue from the Americas, followed by Europe, the Middle East and Africa, and the Asia-Pacific region.

Share on Social Networks: